2 completed, 2 recruiting, 1 unknown. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Recruiting 2, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Adverse Drug Event: new trials by email Literature Review of Adverse Drug Event trials Research Report on Adverse Drug Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of GC101 TIL in Advanced Melanoma (BZ) GC101 TIL - Tumor Infiltrating Lymphocytes, Safety | Phase 1 / Phase 2 | Completed | Shanghai Juncell Therapeutics | 18 | 2023-11-08 | 2025-12-23 |
| Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma Ad-TD-nsIL12 - Oncolytic Virus, Diffuse Intrinsic Pontine Glioma | Phase 1 | Recruiting | Capital Medical University | 18 | 2023-01-04 | 2024-02-28 |
| Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma Ad-TD-nsIL12 - Oncolytic Virus, Diffuse Intrinsic Pontine Glioma | Phase 1 | Recruiting | Capital Medical University | 18 | 2023-01-04 | 2024-02-28 |
| A Phase I Study of GC101 TIL in Advanced Solid Tumors TIL therapy - Tumor Infiltrating Lymphocytes, Safety | Phase 1 | Completed | Shanghai Juncell Therapeutics | 43 | 2022-10-12 | 2025-12-10 |
| TIL and Anti-PD1 in Metastatic Melanoma Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha - Toxicity, Drug, Adverse Drug Event | Phase 1 / Phase 2 | Unknown | Leiden University | 34 | 2018-07-31 | 2023-12-12 |
Drug-Related Side Effects and Adverse Reactions (5) · Diffuse Intrinsic Pontine Glioma (2) · Melanoma (2)
Chemically-Induced Disorders (5) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Nerve Tissue (4) · Neuroectodermal Tumors (4) · Brain Diseases (2) · Brain Neoplasms (2) · Brain Stem Neoplasms (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Glioma (2) · Infratentorial Neoplasms (2) · Neoplasms, Glandular and Epithelial (2)
Nivolumab (1)
Capital Medical University (2) · Shanghai Juncell Therapeutics (2) · Leiden University (1)
China (4) · Netherlands (1)
Hongwei Zhang, Prof. (2) · Ellen Kapiteijn, Dr. (1) · Jun Guo (1)